Quay Pharma partnering this years Microbiome Movement – Drug Development & Nutrition Asia Summit
Quay Pharma is an independent, privately-owned Contract Development Manufacturing Organisation (CDMO). They specialise in the development of innovative new entities for biotech companies, globally. They are proud to be attending and partnering this years event.
Part of the globally recognised Microbiome Movement, the 2nd Microbiome Movement – Drug Development & Nutrition Asia Summit will return to help translational microbiome researchers in APAC discover, develop and deliver the future generation of microbiome-based products across therapeutic and nutritional industry applications.
Join and interact with industry and academic key opinion leaders from Asia’s prominent microbiome-focused organisations to accelerate your knowledge of the field, overcome key challenges in translating your microbiome research to commercial reality and help deliver a new future for healthcare.